Avanir Licenses Concert’s Deuterium-Modified Dextromethorphan Products in Potential US$200 M Deal

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/52B0FC95.svg?ark=w1%2F20260515%2F52B0FC95)](https://nobleid.org/work/w1/20260515/52B0FC95)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors